117 related articles for article (PubMed ID: 3178248)
1. Controlled study of plasma exchange in pemphigus.
Guillaume JC; Roujeau JC; Morel P; Doutre MS; Guillot B; Lambert D; Lauret P; Lorette G; Prigent F; Triller R
Arch Dermatol; 1988 Nov; 124(11):1659-63. PubMed ID: 3178248
[TBL] [Abstract][Full Text] [Related]
2. Plasma exchange in pemphigus. Uncontrolled study of ten patients.
Roujeau JC; Andre C; Joneau Fabre M; Lauret P; Flechet ML; Kalis B; Revuz J; Touraine R
Arch Dermatol; 1983 Mar; 119(3):215-21. PubMed ID: 6824359
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
[TBL] [Abstract][Full Text] [Related]
4. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.
Guillaume JC; Vaillant L; Bernard P; Picard C; Prost C; Labeille B; Guillot B; Foldès-Pauwels C; Prigent F; Joly P
Arch Dermatol; 1993 Jan; 129(1):49-53. PubMed ID: 8420491
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
[TBL] [Abstract][Full Text] [Related]
6. [A study on the therapy and prognosis of pemphigus vulgaris].
Yoshiike K; Shiozawa E; Yamada H; Taneda A; Takamori K; Ogawa H
Nihon Hifuka Gakkai Zasshi; 1990 Jun; 100(7):773-8. PubMed ID: 2214242
[TBL] [Abstract][Full Text] [Related]
7. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris.
Euler HH; Löffler H; Christophers E
Arch Dermatol; 1987 Sep; 123(9):1205-10. PubMed ID: 3632005
[TBL] [Abstract][Full Text] [Related]
8. [Plasma exchange in pemphigus vulgaris].
Hunziker T; Schwarzenbach HR; Krebs A; Nydegger UE; Camponovo F; Hess M
Schweiz Med Wochenschr; 1981 Oct; 111(44):1637-42. PubMed ID: 7302547
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
10. IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris.
Bystryn JC; Jiao D
Autoimmunity; 2006 Nov; 39(7):601-7. PubMed ID: 17101504
[TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis therapy of pemphigus and bullous pemphigoid.
Roujeau JC
Semin Dermatol; 1988 Sep; 7(3):195-200. PubMed ID: 3153444
[TBL] [Abstract][Full Text] [Related]
12. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D
Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind trial of intravenous immunoglobulin for pemphigus.
Amagai M; Ikeda S; Shimizu H; Iizuka H; Hanada K; Aiba S; Kaneko F; Izaki S; Tamaki K; Ikezawa Z; Takigawa M; Seishima M; Tanaka T; Miyachi Y; Katayama I; Horiguchi Y; Miyagawa S; Furukawa F; Iwatsuki K; Hide M; Tokura Y; Furue M; Hashimoto T; Ihn H; Fujiwara S; Nishikawa T; Ogawa H; Kitajima Y; Hashimoto K;
J Am Acad Dermatol; 2009 Apr; 60(4):595-603. PubMed ID: 19293008
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.
Jayne DR; Gaskin G; Rasmussen N; Abramowicz D; Ferrario F; Guillevin L; Mirapeix E; Savage CO; Sinico RA; Stegeman CA; Westman KW; van der Woude FJ; de Lind van Wijngaarden RA; Pusey CD;
J Am Soc Nephrol; 2007 Jul; 18(7):2180-8. PubMed ID: 17582159
[TBL] [Abstract][Full Text] [Related]
15. [Immunoglobulins or plasma exchange? Synchronization of plasma exchange and intravenous polyvalent immunoglobulins. A consecutive study of 11 patients].
Bussel A; Boulechfar H; Naim R
Ann Med Interne (Paris); 1993; 144(8):532-8. PubMed ID: 8179243
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
Werth VP
Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic plasma exchange as a crisis option in severe pemphigus vulgaris.
Ranugha PS; Kumari R; Kartha LB; Parameswaran S; Thappa DM
Indian J Dermatol Venereol Leprol; 2012; 78(4):508-10. PubMed ID: 22772632
[No Abstract] [Full Text] [Related]
18. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
[TBL] [Abstract][Full Text] [Related]
19. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
20. Removal of prednisone and prednisolone by plasma exchange.
Stigelman WH; Henry DH; Talbert RL; Townsend RJ
Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
